campylobacter jejuni strain cg8421
Cell therapyexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2007 (NCT00434798)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- campylobacter jejuni strain cg8421
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01048112 | Phase 1 | Jan 1, 2010 | United States Army, United States Navy, University of Vermont |
| NCT00434798 | Phase 1 | Feb 1, 2007 | TD Vaccines A/S, United States Navy, University of Vermont |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| United States Navy | Government | 2 | 0 | 1 | 2007 |
| University of Vermont | Academic/Hospital | 2 | 2 | 1 | 2007 |
| TD Vaccines A/S | For profit | 1 | 0 | 1 | 2007 |
| United States Army | Government | 1 | 0 | 1 | 2010 |
4 organizations
Page 1 / 1